Cite
Clinical characteristics, treatment patterns, and persistence in individuals with type 2 diabetes initiating a glucagon-like peptide-1 receptor agonist: A retrospective analysis of the Diabetes Prospective Follow-Up Registry.
MLA
Jung, Heike, et al. “Clinical Characteristics, Treatment Patterns, and Persistence in Individuals with Type 2 Diabetes Initiating a Glucagon-like Peptide-1 Receptor Agonist: A Retrospective Analysis of the Diabetes Prospective Follow-Up Registry.” Diabetes, Obesity & Metabolism, vol. 25, no. 7, July 2023, pp. 1813–22. EBSCOhost, https://doi.org/10.1111/dom.15038.
APA
Jung, H., Tittel, S. R., Schloot, N. C., Heitmann, E., Otto, T., Lebrec, J., Pavel, M., & Lanzinger, S. (2023). Clinical characteristics, treatment patterns, and persistence in individuals with type 2 diabetes initiating a glucagon-like peptide-1 receptor agonist: A retrospective analysis of the Diabetes Prospective Follow-Up Registry. Diabetes, Obesity & Metabolism, 25(7), 1813–1822. https://doi.org/10.1111/dom.15038
Chicago
Jung, Heike, Sascha R Tittel, Nanette C Schloot, Elke Heitmann, Thorsten Otto, Jeremie Lebrec, Marianne Pavel, and Stefanie Lanzinger. 2023. “Clinical Characteristics, Treatment Patterns, and Persistence in Individuals with Type 2 Diabetes Initiating a Glucagon-like Peptide-1 Receptor Agonist: A Retrospective Analysis of the Diabetes Prospective Follow-Up Registry.” Diabetes, Obesity & Metabolism 25 (7): 1813–22. doi:10.1111/dom.15038.